Anterior vs CoverMyMeds
Side-by-side comparison of AI visibility scores, market position, and capabilities
London and New York AI platform automating insurance prior authorization; reads patient clinical records to extract evidence justifying medical necessity and cut treatment delays.
About
Anterior is a London and New York-based healthtech company that applies AI to automate the prior authorization process, one of the most burdensome administrative tasks in U.S. healthcare. Prior authorization requires physicians to submit clinical evidence to insurance companies justifying the medical necessity of treatments, procedures, or medications — a process that consumes significant physician and staff time and causes treatment delays that harm patient outcomes. Anterior's AI reads patient clinical records, identifies the relevant clinical criteria required by the insurer, extracts supporting evidence from the patient's history, and generates complete prior auth submissions automatically. The platform also predicts approval likelihood and flags cases likely to require clinical review, helping health system staff prioritize their work. Founded in 2022, Anterior raised funding from investors including Sequoia Capital and has rapidly signed health system customers facing acute prior authorization burdens. The company's approach addresses a systemically inefficient process that costs the U.S. healthcare system an estimated $35B annually in administrative waste.
Largest prior authorization network in the US connecting 75K+ pharmacies, 750K+ providers, and all payers. Columbus OH; acquired by McKesson; available free to providers and pharmacies; processes millions of PA requests annually for specialty and retail prescriptions at no provider cost.
About
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline the authorization process for prescription medications. Founded in 2008 in Columbus, Ohio, and acquired by McKesson Corporation in 2017, CoverMyMeds processes millions of prior authorization requests annually and has become foundational infrastructure for the US pharmacy and specialty medication market. The platform is available at no cost to providers and pharmacies and is funded through health plan and PBM partnerships.\n\nCoverMyMeds' network effect is central to its value: because the platform is used by the vast majority of pharmacies and a very large share of prescribing providers, payers can reach their entire provider and pharmacy network through a single connection. The platform supports real-time benefit checks that show the formulary status and prior authorization requirements for a drug at the point of prescribing, enabling providers to make more informed prescribing decisions before a patient reaches the pharmacy counter. Automated electronic prior authorization (ePA) workflows reduce approval times from days to hours for eligible drug-payer combinations.\n\nAs part of McKesson, CoverMyMeds has expanded its capabilities to include specialty medication access solutions, patient assistance program enrollment, and medication adherence tools. The company's RxCrossroads subsidiary provides hub services for specialty pharmaceutical manufacturers, creating a comprehensive access ecosystem that spans from initial authorization through patient support and adherence management.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.